Winona B.

Global Regulatory Science and Policy | Views are my own, unless they are yours.

[Winona B. @iwinniebee]

Be among the first to read our publication on "Regulatory Agilities in the time of #COVID-19" (pre-proof), which provides some analysis and examples of agilities adopted by #regulatoryauthorities during this pandemic. #flexibilities #regulatoryscience

[Clinical Therapeutics @clinthe]

Regulatory agilities in the time of COVID-19: Overview, Trends and Opportunities https://t.co/oIQfSrDvIm

[OCDE @OCDE_fr]

Confinement strict, fermeture des écoles, soutien financier aux entreprises… Quelles mesures ont été prises à travers le monde pour faire face à la crise du #coronavirus ? 😷

Retrouvez toutes ces informations pour + de 9️⃣0️⃣ pays ici ➡️ https://t.co/bIct6KVRrn #COVID19

[EU Medicines Agency @EMA_News]

EMA’s human medicines committee (#CHMP) has started a ‘rolling review’ of data on the use of the investigational antiviral medicine #remdesivir for the treatment of #COVID19.
#coronavirus
👉https://t.co/7WqvyQXcXk

[Winona B. @iwinniebee]

Check out our new paper on how #realworlddata has been applied in new drug applications and line extensions. #regulatory #regulatoryscience

[Clinical Therapeutics @clinthe]

Use of real-world data for new drug applications and line extensions https://t.co/MF87qt2b0n

[Clinical Therapeutics @clinthe]

Use of real-world data for new drug applications and line extensions https://t.co/MF87qt2b0n

[Stella Kyriakides @SKyriakidesEU]

@EU_Commission has launched a joint 🌍 call for action to develop fast & equitable access to safe, effective and affordable diagnostics, therapeutics & vaccines against #COVID19.
Starting on 4️⃣ May 2020, the world becomes one #GlobalResponse.
#StrongerTogether

[Winona B. @iwinniebee]

Happy to share our recently published #journal article on the use of #realworlddata in #regulatory decision-making for #newdrugapplications and #lineextensions: https://t.co/1I4ZnPe88k #observationaldata #rwe #rwd #realworldevidence #regulatoryscience #regulatorydecision

[EU Medicines Agency @EMA_News]

📢Healthcare professionals are recommended to closely monitor #COVID19 patients receiving #chloroquine or #hydroxychloroquine and to take into account pre-existing heart problems that can make patients more prone to heart rhythm issues:
👉https://t.co/mbFx7bQJ5z

[EFPIA @EFPIA]

#RealWorldEvidence is showing its value in tackling #COVID19, providing continuous insights on treatments' effectiveness. How can #RWD & #RWE help us deliver high quality and safe vaccines and treatments for patients? #RegulatoryRoadToInnovation https://t.co/zwzpDOsKXN

[Sanofi @sanofi]

#SanofiActs
In this #COVID19 crisis, Sanofi stands ready to assist as many countries as possible by providing #hydroxychloroquine. If ongoing clinical studies demonstrate its efficacy and safety, Sanofi will continue to donate the medicine. https://t.co/6t8Vd95eVq

[EU Medicines Agency @EMA_News]

Supply of medicines is a critical concern for medicine regulators. What are the new measures taken by EU authorities to support availability of 💊💊 used in the #COVID19 pandemic? 📢Check out our communication: 👉https://t.co/pQjIwgdioU

[EU One Health @EU_Health]

A little reminder: there are still no treatments or cures for #coronavirus

#FactsMatter: We all want an authorised treatment/vaccine to be available as soon as possible, but we also need them to be effective and safe for patients.

#COVID19

[Sanofi @sanofi]

"As #COVID19 continues to spread, it is our job in the healthcare industry to do our part, which includes not only developing vaccines and treatments, but also keeping the public informed" Hear from Paul Hudson, our CEO, who shares Sanofi's commitment: https://t.co/XGK5KzB116

[EFPIA @EFPIA]

#WeWontRest: our members will continue to work around the clock to find new diagnostic tests, vaccines & treatments to help in the fight against #COVID2019
https://t.co/XeOEWPkl4A

[EFPIA @EFPIA]

What is the industry in Europe doing to help in the fight against the coronavirus? What is a vaccine? And how do they work? Check our #COVID19 Q&A https://t.co/gMUSjcn5LU #WeWontRest

[Winona B. @iwinniebee]

@Ellieeeeebelly Félicitations Ellie! Such great news!

[DigitalHealthEurope @DHE_2020]

JUST LAUNCHED The @DHE_2020 twinning scheme is funding 28 #twinnings committed to scaling up #digitalhealth and care.
Don’t miss #DigitalHealthEurope Call for Twinnings
https://t.co/tuOI1NYDP5
@eHealth_EU #Call4Twinnings #eHealth #integratedcare Deadline: 4 May 2020

[EU Medicines Agency @EMA_News]

Finding effective treatment for #patients with a #RareDisease can be difficult. EMA is committed to facilitating development of #OrphanMedicines to help diagnose and treat these patients: https://t.co/vE3DLaGpNY #RareDiseaseDay

[Thomas B. Cueni @ThomasCueni]

Speaking to @ACANU_Geneva, I highlighted that the current #COVID19 outbreak is everyone's responsibility and requires solidarity, collaboration & innovative efforts. As #industry, we're committed to developing vaccines, therapies & diagnostics to contain the disease quickly.

[European Ombudsman @EUombudsman]

🆕 We welcome today's @EUCourtPress ruling confirming public access to clinical study trials.

⚖️ judgement 👉 https://t.co/XZUCB4EfMU

We worked with @EMA_News over many years for greater transparency in this area 👇

https://t.co/RDvdy0ebff
https://t.co/WChXTx3aV2